Parkinson's Disease Trial, Recruiting NCT05773885 Sponsor: IRCCS San Raffaele Roma Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05773885
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 30 and 80 years old
  • People who have been diagnosed with Parkinson's Disease according to the Movement Disorders Society's diagnostic criteria
  • People whose Parkinson's symptoms are at a moderate stage (Hoehn & Yahr score between 2 and 3, measured when medication is working well) (confirm with trial site)
  • People who do not experience significant involuntary movements (dyskinesias), based on a standard assessment score (confirm with trial site)
  • People who show no significant signs of cognitive (thinking and memory) problems, based on a standard screening test score of 18 or above
  • People whose Parkinson's medication has been stable and unchanged for a period of time
  • People who have access to the internet for remote rehabilitation sessions
  • People who have a caregiver available to be present during remote rehabilitation sessions
  • People who have a sufficient level of understanding and language ability to follow the study procedures
  • People who are willing and able to sign an informed consent form

Who may not be able to join:

  • People whose cognitive difficulties or low likelihood of following instructions would prevent them from using the remote rehabilitation system
  • People who have other neurological conditions, psychiatric complications, or personality disorders
  • People who have muscle or joint diseases that affect their ability to move
  • People who experience significant involuntary movements (dyskinesias), based on a standard assessment score above a certain threshold (confirm with trial site)
  • People whose cognitive (thinking and memory) screening test score falls below 18
  • People with severe difficulties in understanding or communicating that would prevent them from following study procedures
  • People who have blurred or significantly reduced vision
  • People with hearing or speech difficulties that would affect their ability to take part in the rehabilitation system
  • People who are not willing or able to sign the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr. Sanaz Pournajaf, DPT, IRCCS San Raffaele Roma

Phone: +39 0652252405

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele Roma
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
30 March 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) - part II

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov